| Vascular normalization in Rgs5-deficient tumours promotes immune destruction J Hamzah, M Jugold, F Kiessling, P Rigby, M Manzur, HH Marti, T Rabie, ... Nature 453 (7193), 410-414, 2008 | 619 | 2008 |
| Transtumoral targeting enabled by a novel neuropilin-binding peptide L Roth, L Agemy, VR Kotamraju, G Braun, T Teesalu, KN Sugahara, ... Oncogene 31 (33), 3754-3763, 2012 | 261 | 2012 |
| Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy A Johansson, J Hamzah, CJ Payne, R Ganss Proceedings of the National Academy of Sciences 109 (20), 7841-7846, 2012 | 186 | 2012 |
| Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice J Hamzah, VR Kotamraju, JW Seo, L Agemy, V Fogal, LM Mahakian, ... Proceedings of the National Academy of Sciences 108 (17), 7154-7159, 2011 | 126 | 2011 |
| 64Cu-Labeled LyP-1-Dendrimer for PET-CT Imaging of Atherosclerotic Plaque JW Seo, H Baek, LM Mahakian, J Kusunose, J Hamzah, E Ruoslahti, ... Bioconjugate chemistry 25 (2), 231-239, 2014 | 88 | 2014 |
| Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules B He, A Jabouille, V Steri, A Johansson‐Percival, IP Michael, ... The Journal of pathology 245 (2), 209-221, 2018 | 84 | 2018 |
| Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases O Erster, JM Thomas, J Hamzah, AM Jabaiah, JA Getz, TD Schoep, ... Journal of controlled release 161 (3), 804-812, 2012 | 81 | 2012 |
| Magnetic susceptibility of iron in malaria-infected red blood cells S Hackett, J Hamzah, TME Davis, TG St Pierre Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1792 (2), 93-99, 2009 | 81 | 2009 |
| Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice J Hamzah, D Nelson, G Moldenhauer, B Arnold, GJ Hämmerling, R Ganss The Journal of clinical investigation 118 (5), 1691-1699, 2008 | 76 | 2008 |
| Intratumoral LIGHT restores pericyte contractile properties and vessel integrity A Johansson-Percival, ZJ Li, DD Lakhiani, B He, X Wang, J Hamzah, ... Cell reports 13 (12), 2687-2698, 2015 | 70 | 2015 |
| Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea HA Karunajeewa, J Reeder, K Lorry, E Dabod, J Hamzah, M Page-Sharp, ... Antimicrobial agents and chemotherapy 50 (3), 968-974, 2006 | 66 | 2006 |
| Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model J Hamzah, JG Altin, T Herringson, CR Parish, GJ Hämmerling, ... The Journal of Immunology 183 (2), 1091-1098, 2009 | 61 | 2009 |
| Remodeling of metastatic vasculature reduces lung colonization and sensitizes overt metastases to immunotherapy B He, A Johansson-Percival, J Backhouse, J Li, GYF Lee, J Hamzah, ... Cell reports 30 (3), 714-724. e5, 2020 | 56 | 2020 |
| More than a scaffold: stromal modulation of tumor immunity A Johansson, J Hamzah, R Ganss Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1865 (1), 3-13, 2016 | 46 | 2016 |
| In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs TME Davis, J Hamzah, KF Ilett, HA Karunajeewa, JC Reeder, KT Batty, ... Antimicrobial agents and chemotherapy 50 (8), 2883-2885, 2006 | 38 | 2006 |
| Modulation of the" blood-tumor" barrier improves immunotherapy M Manzur, J Hamzah, R Ganss Cell cycle 7 (16), 2452-2455, 2008 | 37 | 2008 |
| Modulation of g protein signaling normalizes tumor vessels M Manzur, J Hamzah, R Ganss Cancer research 69 (2), 396-399, 2009 | 32 | 2009 |
| In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists J Hamzah, TS Skinner-Adams, TME Davis Acta Tropica 87 (3), 345-353, 2003 | 30 | 2003 |
| In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone J Hamzah, T Skinner-Adams, TME Davis Acta tropica 74 (1), 39-42, 2000 | 30 | 2000 |
| Immune‐mediated ECM depletion improves tumour perfusion and payload delivery YL Yeow, VR Kotamraju, X Wang, M Chopra, N Azme, J Wu, TD Schoep, ... EMBO molecular medicine 11 (12), e10923, 2019 | 29 | 2019 |
